Aion Therapeutic Inc (CSE:AION) CEO, Dr Stephen Barnhill presents at Proactive's One2One virtual investor forum.
The Toronto-based group recently filed five patent applications with the US Patent and Trademark Office related to the combination of medical cannabis with edible and psychedelic mushrooms.
Price: 0.12 CAD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of AION Therapeutic Inc. named herein, including the promotion by the Company of AION Therapeutic Inc. in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
We are delighted to invite you to attend the next Proactive ONE2ONE Investor Forum which is taking place on Tuesday February 23rd from 1pm EST via our online interactive webinar conference Proactive continues to bring you the best investment opportunities safely to the comfort of your own...
Basic Materials
Prev article
